Trilotab^®, the First Chewable, Flavoured & Divisible Trilostane Tablet to Treat Cushing’s Syndrome in Dogs

We are delighted to announce the launch of NEW Trilotab^®, the first chewable, flavoured and divisible trilostane tablet to treat Cushing’s syndrome in dogs

New Tramvetol^® - Licensed Tramadol Tablets for Dogs

Virbac are pleased to announce the launch of Tramvetol^®, licensed tramadol tablets for the treatment of acute and chronic pain in dogs.

Virbac Supports WVI African Painted Dog Conservation Project

Virbac are pleased to confirm their continued support to Wildlife Vets International in their campaign to reduce the risk of population decline in the African painted dog due to disease.

How Important Is an Ear Cleaner in the Short and Long-Term Management of Otitis Externa in Dogs?

Otitis externa is a very common condition in dogs, yet can be difficult to manage, successfully, in practice. Once the patient has been examined and a diagnosis has been established, the choice of treatment prescribed will be the key to success in treating otitis externa.

Travelling Dogs Going to Sunnier Climes? Skin Lesions? Don’t Forget Leishmania!

With soaring numbers of animals crossing the channel every year, as well as rescue dogs from abroad and owners moving to this country, UK vets are confronted with diseases that were very rarely identified before the PETS scheme made travelling beloved pets to EU countries much easier.

Introducing Eradia - The First Liquid Metronidazole For Dogs

Virbac are delighted to announce the launch of Eradia, the first and only metronidazole for dogs in a flavoured oral suspension.

We Are Excited to Announce the Arrival of Canigen^® Bb, A New Injectable Bordetella Bronchiseptica Vaccine for Dogs

We are pleased to announce the addition of Canigen^® Bb, a new injectable Bordetella bronchiseptica vaccine for dogs, to our comprehensive companion animal vaccine range.